Balaji Amines faces court summons over Drugs and Cosmetics Act charges
- Legal
- Chemicals - Inorganic
Reviewed byKeshav SehgalBlacklitt Research
Balaji Amines (NSE: BALAMINES) has received summons from the City Civil and Sessions Court, Ahmedabad, requiring the company and all its directors to appear on 4 Nov 2026 over alleged violations of the Drugs and Cosmetics Act, 1940, it said in a filing on 03 Nov 2026. The company says the matter has no material impact on its financials, operations or other activities.
What the court has asked for
The summons is dated 15 Oct 2026 and was dispatched on 31 Oct 2026. The company received it on 3 Nov 2026, the day it filed the disclosure, and the court requires the company and its directors to appear in person or through a pleader before the Magistrate or Principal Judge on 4 Nov 2026.
The alleged violations fall under Sections 16(1)(a), 18(a)(i), 18(c), 34, 27(b)(ii) and 27(d) of the Drugs and Cosmetics Act, 1940.
Scale against the company
Balaji Amines is a chemicals company with a market value of ₹5,750 crore at the 03 Nov 2026 close of ₹1,774.70 a share. In the latest quarter, Q1 FY27 on a consolidated basis, it reported total income of ₹461.45 crore and net profit of ₹78.12 crore.
The company also filed its results for the quarter and half year ended 30 Sep 2026 on 02 Nov 2026, the day before this disclosure.
What the summons means for Balaji Amines' shareholders
The summons names the company and all its directors, and the company states there is no material impact on its financials, operations or other activities. The next dated step is the court appearance on 4 Nov 2026.
The filing does not say how the company or its directors have responded, what the outcome of the appearance will be, or whether any penalty or amount is linked to the alleged violations. The names of the directors summoned are also not stated.
At a glance
| Item | Detail |
|---|---|
| Authority | City Civil and Sessions Court, Ahmedabad (Principal Judge, City Civil Court) |
| Summons dated | 15 Oct 2026 |
| Dispatched | 31 Oct 2026 |
| Received by company | 3 Nov 2026 |
| Court appearance | 4 Nov 2026 |
| Act cited | Drugs and Cosmetics Act, 1940 |
| Company's view of impact | No material impact on financials, operations or other activities |
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
